AAV-Mediated Gene Transfer for Treatment of Hemophilia

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|5|3|349-360

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.5, Iss.3, 2005-06, pp. : 349-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases

By  

Current Gene Therapy, Vol. 10, Iss. 5, 2010-01 ,pp. : 371-380

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: AAV-Mediated Gene Therapy for the Treatment of Retinal Diseases (Guest Editor: Fabienne Rolling)]

By  

Current Gene Therapy, Vol. 10, Iss. 5, 2010-10 ,pp. : 318-318

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Recombinant AAV-Mediated Gene Therapy for Lung Diseases

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-06 ,pp. : 361-366

Bentham Science Publishers

Access to resources Recommend Favorite

Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite

The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 381-394

Bentham Science Publishers

Access to resources Recommend Favorite